Unified Patents, Inc. v. Wecrevention Inc.
Pending- Docket:
- IPR2026-00239
An Inter Partes Review challenging US Patent 9164942, owned by Wecrevention Inc., was initiated by Unified Patents, Inc. and is currently pending before the PTAB.
Defendant
1 case as defendant.
Wecrevention Inc. is a company operating in the intellectual property industry, primarily functioning as a patent assertion entity (PAE). It is a wholly-owned subsidiary of Etron Technology, Inc., a Taiwanese public company established in 1991, specializing in the design, manufacturing, and sale of niche memory chips and logic chip products. Etron Technology, Inc. reported an investment of $3,209 thousand in Wecrevention Inc. as of 2023.
Wecrevention Inc. engages in patent monetization and enforcement activities, asserting patents, some of which are related to its parent company's semiconductor technology. While no specific products or services beyond patent assertion are publicly detailed for Wecrevention Inc. itself, its operations are centered on managing and licensing its patent portfolio.
In terms of patent litigation, Wecrevention Inc. primarily acts as a patent holder asserting its intellectual property. Although the provided database shows one case where Wecrevention Inc. is a defendant (Unified Patents, Inc. v. Wecrevention Inc. at the Patent Trial and Appeal Board), this case is an inter partes review (IPR) initiated by Unified Patents, a defensive patent organization, to challenge one of Wecrevention's patents (Patent 9,164,942). This defensive challenge against Wecrevention highlights its role as a patent owner. Additional public records indicate Wecrevention Inc. has initiated patent infringement lawsuits as a plaintiff against major technology companies, including Apple Inc. and Dell Inc., with cases filed in patent-friendly venues such as the Western and Eastern Districts of Texas.
An Inter Partes Review challenging US Patent 9164942, owned by Wecrevention Inc., was initiated by Unified Patents, Inc. and is currently pending before the PTAB.